These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 6444774
1. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein. Conzelmann E, Sandhoff K. Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774 [Abstract] [Full Text] [Related]
2. Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A. Conzelmann E, Sandhoff K. Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1837-49. PubMed ID: 527942 [Abstract] [Full Text] [Related]
3. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A. Meier EM, Schwarzmann G, Fürst W, Sandhoff K. J Biol Chem; 1991 Jan 25; 266(3):1879-87. PubMed ID: 1824846 [Abstract] [Full Text] [Related]
4. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. Conzelmann E, Sandhoff K. Proc Natl Acad Sci U S A; 1978 Aug 25; 75(8):3979-83. PubMed ID: 99746 [Abstract] [Full Text] [Related]
5. Specificity of mouse GM2 activator protein and beta-N-acetylhexosaminidases A and B. Similarities and differences with their human counterparts in the catabolism of GM2. Yuziuk JA, Bertoni C, Beccari T, Orlacchio A, Wu YY, Li SC, Li YT. J Biol Chem; 1998 Jan 02; 273(1):66-72. PubMed ID: 9417048 [Abstract] [Full Text] [Related]
6. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein. Inui K, Grebner EE, Jackson LG, Wenger DA. Am J Hum Genet; 1983 Jul 02; 35(4):551-64. PubMed ID: 6224417 [Abstract] [Full Text] [Related]
7. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts. O'Brien JS, Norden GW, Miller AL, Frost RG, Kelly TE. Clin Genet; 1977 Mar 02; 11(3):171-83. PubMed ID: 13950 [Abstract] [Full Text] [Related]
8. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2. Conzelmann E, Burg J, Stephan G, Sandhoff K. Eur J Biochem; 1982 Apr 01; 123(2):455-64. PubMed ID: 6210531 [Abstract] [Full Text] [Related]
9. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis. Hirabayashi Y, Li YT, Li SC. J Neurochem; 1983 Jan 01; 40(1):168-75. PubMed ID: 6848657 [Abstract] [Full Text] [Related]
10. Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A. Yadao F, Hechtman P, Kaplan F. Biochim Biophys Acta; 1997 Jun 20; 1340(1):45-52. PubMed ID: 9217013 [Abstract] [Full Text] [Related]
11. Substrate binding properties of the human liver hexosaminidase A activator protein. Hechtman P, Isaacs C, Smith-Jones L. Can J Biochem Cell Biol; 1985 Aug 20; 63(8):830-8. PubMed ID: 2933135 [Abstract] [Full Text] [Related]
12. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes. Bayleran J, Hechtman P, Saray W. Clin Chim Acta; 1984 Nov 15; 143(2):73-89. PubMed ID: 6239713 [Abstract] [Full Text] [Related]